Archived articles

Drugs

Q+A
The science and safety of marijuana
Published July 10, 2023
Experimental psychologist Ryan Vandrey discusses the science and safety of recreational cannabis on the heels of legalization in Maryland
Pharmacology
Toad venom therapy
Published Summer 2019
Psychoactive mushrooms may help individuals with depression and anxiety, but each trip can last from four to six hours. Enter the toad. / Johns Hopkins Magazine
Drug policy
A look inside early efforts to create safe consumption sites in the U.S.
Published Feb 22, 2019
Study analyzes early policy efforts, identifies challenges and paths forward / School of Public Health
Work Hard/Play Smart
Brain chemistry lesson
Published Oct 13, 2017
Student drug, alcohol abuse awareness campaign begins with talk by Hopkins neuroscientist Linda Gorman
Commentary
Over-the-counter, underregulated
Published July 24, 2017
FDA creates risks with insufficient regulation of potentially harmful nonprescription meds, public health expert says / Politico
Pure Ecstasy?
Pill testing could reduce risks
Published July 10, 2017
Many at music festivals, raves say they wouldn't take Ecstasy pills shown to be adulterated or fake
Recent overdose incidents prompt warnings about opioid risks
Published May 16, 2017
Johns Hopkins experts discuss U.S. opioid epidemic, signs of an overdose, campus resources
Race in America
War on drugs rooted in 'racist policies'
Published April 19, 2017
U.S. is preoccupied with morality of drug use, Columbia University expert Carl Hart says
Race in America
Drugs and discrimination
Published April 6, 2017
Columbia's Carl Hart will discuss racial bias in U.S. drug policy, enforcement as part of Race in America series
Drug policy
War on drugs undercuts public health, experts say
Published March 24, 2016
Health commission concludes current policies increase risk of death, exacerbate ongoing health crises worldwide / School of Public Health